Pfizer’s $64 billion bet on ‘huge’ technology

US pharmaceutical giant Pfizer has announced a deal to buy biotech firm Seagen, which specialises in innovative cancer treatment, for $US43 billion ($A64.6 billion).

via Technology | news.com.au — Australia’s leading news site https://ift.tt/rfoUJtq